Ebola Cases in Italy Spark Health Concerns
Two aid workers have returned to Europe with suspected cases of Ebola, raising concerns in the northern Lombardy region of Italy. The man and woman, who had been on a three-month trip to Uganda, have developed symptoms consistent with the virus, including high fever, nausea, vomiting, and intestinal problems.
The situation has led to a health alert in the region. Both individuals have been transferred to Milan’s Sacco Hospital, a facility specialized in handling high-risk infectious diseases. However, officials are still uncertain if the symptoms are indeed caused by Ebola.
Lombardy’s regional welfare minister, Guido Bertolaso, stated that “there is still no certainty that this is Ebola.” He expressed hope that the test results will be negative. Doctors have also considered other possibilities, such as malaria, particularly cerebral malaria in the case of the 30-year-old woman, who may require intensive care due to severe symptoms, including a very high fever and mild neurological issues.
The man, from Bulgarograsso, is displaying milder symptoms, such as a temperature of around 38°C and gastrointestinal problems. Despite these concerns, the Italian Health Ministry has stated that the risk of Ebola in Italy remains very low.
Global Spread of Ebola
The current outbreak of Ebola is occurring in the Democratic Republic of Congo (DRC), where more than 900 suspected cases and 234 deaths have been reported. This includes three Red Cross volunteers who are believed to have contracted the virus while handling dead bodies.
The DRC has seen a deadly strain of the virus spreading rapidly, with no protective vaccine available. Experts fear this could lead to a major global health crisis. In previous outbreaks, the virus has killed over half of those infected, often due to internal bleeding and organ failure.
The European Commission’s Health Security Committee held a meeting to discuss the Ebola emergency in Africa. All flights to and from Bunia, the city in eastern DRC where most cases have occurred, have been grounded. However, experts believe the virus may have already spread to neighboring countries like South Sudan.
Vaccine Development and Challenges
A life-saving jab exists for the Zaire variant of Ebola, but the current outbreak is caused by a different strain called Bundibugyo. Scientists at Oxford University are working to develop a vaccine against this variant, but it will take two to three months before human testing can begin. This means that patients in Africa are unlikely to receive the vaccine within the next six months.
Even if the vaccine is successful, there is no guarantee it will be effective. Symptoms of all Ebola variants are similar, starting with flu-like symptoms and progressing to internal bleeding, organ failure, and death. Patients can carry the virus for up to 21 days before showing symptoms, during which time they may become infectious.
International Response and Warnings
While the World Health Organization (WHO) has escalated its risk assessment for the DRC, it claims the global risk remains low. The UK has announced up to £20 million to help contain the outbreak in the eastern region of the DRC. Additionally, the UK has activated a Returning Workers Scheme to monitor healthcare workers returning from Ebola-affected areas.
However, experts warn that the UK is not fully prepared for an Ebola outbreak. Dr. Derek Sloan, an infectious disease expert at St Andrew’s University, emphasized the importance of vigilance and funding for public health. He noted that recent outbreaks, such as Hantavirus on a cruise ship and meningitis in the UK, highlight the need for continued investment in global health and international aid.
“Infectious disease outbreaks such as these in our interconnected world cannot be dismissed as someone else’s problem,” Dr. Sloan said. “These examples show how important it is to maintain this expertise and underline the need to preserve funding for global health and international aid.”
Read more
